Michael Sardano - 12 Dec 2025 Form 4 Insider Report for Sensus Healthcare, Inc. (SRTS)

Reporting relationship: PRESIDENT AND GENERAL COUNSEL, Director
Issuer ticker: SRTS
Reported as of: 12 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Dec 2025, 14:40:20 UTC
Prior SEC filing: 16 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael Sardano

Key filing fact

Michael Sardano filed Form 4 for Sensus Healthcare, Inc. (SRTS) on 16 Dec 2025.

Key facts

This page summarizes Michael Sardano's Form 4 filing for Sensus Healthcare, Inc. (SRTS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Dec 2025, 14:40.

Change

Previous filing in this sequence was filed on 16 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001720602 Primary reporting owner

Sardano Michael

Relationship: PRESIDENT AND GENERAL COUNSEL, Director
Address: 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON
Signature: /s/ Michael Sardano
Signature date: 16 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRTS transaction

Common Stock

Award

Transaction value: $0
Shares: +40,000
Change %: +34%
Price: $0.000000
Shares after: 158,839
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F1

SRTS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,000
Date: 12 Dec 2025
Ownership: spouse
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 40,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan, all of which will vest in four equal annual installments beginning on the first anniversary of the date of grant.

Footnote F2

Shares held by the reporting person's spouse, as to which the reporting person disclaims beneficial ownership.